SBHMY (Sino Biopharmaceutical) Other Stockholders Equity : $-554 Mil (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sino Biopharmaceutical Other Stockholders Equity?

Sino Biopharmaceutical's Other Stockholders Equity for the quarter that ended in Jun. 2024 was $-554 Mil.

Sino Biopharmaceutical's quarterly Other Stockholders Equity increased from Jun. 2023 ($-638 Mil) to Dec. 2023 ($-594 Mil) and increased from Dec. 2023 ($-594 Mil) to Jun. 2024 ($-554 Mil).

Sino Biopharmaceutical's annual Other Stockholders Equity increased from Dec. 2021 ($-795 Mil) to Dec. 2022 ($-684 Mil) and increased from Dec. 2022 ($-684 Mil) to Dec. 2023 ($-594 Mil).

Sino Biopharmaceutical Other Stockholders Equity Historical Data

The historical data trend for Sino Biopharmaceutical's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Other Stockholders Equity Chart

Sino Biopharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Stockholders Equity

Get a 7-Day Free Trial

2,569.27

-794.75

-683.72

-593.78

4,741.47

Sino Biopharmaceutical Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial															-683.72	-638.35	-593.78	-554.01	4,741.47

Sino Biopharmaceutical Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Sino Biopharmaceutical Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (OTCPK:SBHMY) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

SBMFF:USA 01177:Hong Kong SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Listed on the Hong Kong Stock Exchange in 2000, Sino Biopharmaceutical is one of the largest Chinese drugmakers. It started with generic drug manufacturing. Since 2018, Sino Biopharm has been actively pivoting into an innovative drugmaker after the Chinese government launched its volume-based procurement policy for the healthcare industry. As of 2023, 37.8% of the firm's total revenue comes from five innovative drugs and five biosimilar drugs. Sino Biopharm's biggest revenue segment is oncology medicines, accounting for 33.6% of total revenue, followed by hepatitis, surgery/analgesia, respiratory, and cardio-cerebral vascular therapeutic areas.